Malignant tumors of ENT organs

The use of EHF therapy is due to the immunomodulatory and immunostimulating action (to protect the hematopoietic system from the effects of chemo and radiation therapy and reduce toxic reactions after taking antitumor drugs), as well as regenerative and reparative (to enhance regeneration and reduce purulent complications after surgery) action of EHF waves.


EHF therapy is used before the start of treatment when prescribing antitumor drugs to patients with cancer of the larynx, larynx, oral mucosa, upper jaw, in the presence of leukopenia during chemo or radiation therapy and for the treatment of complications of combined treatment (stomatitis, etc.)

Used HF emitters

  1. Frequency 40-43 GHz, wavelength 7.1 mm (red).
  2. Noise-frequency 52-78 GHz (yellow).

Emitters are selected individually for each patient.

Treatment regimen

10-15 sessions of 20-30 min. in 1-3-5-9-12 months (as indicated) after the antitumor therapy.


Impact ZONE: wedge-shaped lattice maze.

Clinical effect and control

Prevention of purulent-inflammatory diseases, reducing the number of relapses and metastases, improving the results of complex treatment. Control is carried out according to the patient’s clinical condition, the state of peripheral blood cells.


Absolute contraindications have not been identified. (See. General contra-indications for EHF-therapy).

p/s Our English is not perfect . We will be happy if you point out transcription errors in comments. And you can write your questions also about this treatment protocol.

Leave a Reply

Your email address will not be published. Required fields are marked *